SCCHN

8 registered clinical trials studyying SCCHN — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Chemo-embolization for Head and Neck Cancer NCT04595981	University of Alabama at Birmingham	Phase 2
Recruiting	Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer NCT06736379	VLP Therapeutics	Phase 1
Completed	Study of XB002 in Subjects With Solid Tumors (JEWEL-101) NCT04925284	Exelixis	Phase 1
Completed	Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma NCT04107103	AHS Cancer Control Alberta	Phase 2
Unknown	Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum R NCT03771820	NanoCarrier Co., Ltd.	Phase 2
Completed	A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small NCT02573259	Pfizer	Phase 1
Unknown	Evaluation of the Overall Quality of Life After the Neck Dissection Retro-spinal Sector (IIb), in Squamous Cel NCT02878655	University Hospital, Caen	—
Unknown	Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN NCT01393184	Peking University	Phase 2